The Institute for Clinical and Economic Review (ICER) in its latest evidence report on treatments for Duchenne muscular dystrophy suggests that PTC Therapeutics' deflazacort would need to see a roughly 73 percent discount to be cost-effective. ICER in its report reviewed Sarepta Therapeutics' […]
Latest Stories
Frenova Goes Global
Frenova Renal Research is looking outward as it aims to expand its scope beyond North America, the organization announced Thursday, July 11. According to a press release, the expansion will enable the organization to "broaden its reach and provide researchers centralized access to an exponentially […]
Trump Scraps Rebate Proposal
The Trump administration this week scrapped a key proposal that would have eliminated pharma-PBM rebates in Medicare, an effort aimed at reducing prescription drug prices, the Washington Post reports. According to the report, the the administration's decision to pull the plug on the proposal […]
What Does Machine Learning Hold for Clinical Trials?
A recent article by Precision for Value's Kellie Rademacher published on Clinical Leader spotlights how machine learning can impact clinical trials. The opportunities that arise from bringing machine learning into the drug development pipeline "seem limitless," Rademacher writes. "While the […]
Report Offers Insight into Value-Based Model
A new report from Prognos, "Success in Managed Markets: Payer Insights," takes a deep dive into the value-based model and its future. The report offers insights into some of the challenges for payers in the value-based paradigm, including "demonstrating outcomes, evidence of cost reduction and […]
Article Spotlights Growing Use of RWE
A recent article published in ISPOR's Value in Health spotlights the growing focus on real-world evidence (RWE) and real-world data (RWD). "In a recent PubMed search, the number of publications that included these terms in the title and abstract has increased by more than 17 times — from 177 […]
More on ACA Hearing
A federal court heard arguments on the constitutionality of the Affordable Care Act health care mandate this week. To read about the 90-minute hearing, click here to read Fierce Healthcare's report. […]
ISPOR Plans Webinar on Machine Learning
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is set to host a July 30 webinar on using machine learning for prediction in HEOR. The online event is set to begin noon EST July 30. "[The webinar] will begin by framing the prediction problem and drawing both […]
ISPOR Launches Presentations Database
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) this week launched the ISPOR Presentations Database, a new HEOR resource. "The ISPOR Presentations Database is one of the most utilized HEOR resources that the society offers," the society said in a press […]
Tool Helps Consumers Find Cheaper Treatment Options
Some health systems in the U.S. have adopted a new pricing tool aimed at helping patients find cheaper treatment options, Kaiser Health News reports. Minnesota-based Allina Health is among the few health systems using the pricing tool, according to the report, which gives physicians access to […]
